Standard dosage of piperacillin leads to subtherapeutic plasma concentrations in burn patients

被引：0
|
作者：
Olberisch, K. [1 ]
Mailaender, P. [2 ]
Kisch, T. [2 ]
Thern, J. [3 ]
Kramme, E. [4 ]
Graf, T. [5 ]
Wicha, S. G. [6 ]
Raasch, W. [1 ]
机构：
[1] Univ Lubeck, Inst Expt & Klin Pharmakol & Toxikol, Lubeck, Germany
[2] Univ Klinikum Schleswig Holstein, Klin Plast Chirurg, Lubeck, Germany
[3] Univ Klinikum Schleswig Holstein, Apotheke, Lubeck, Germany
[4] Univ Klinikum Schleswig Holstein, Med Klin 3, Lubeck, Germany
[5] Univ Klinikum Schleswig Holstein, Med Klin 2, Lubeck, Germany
[6] Uppsala Univ, Pharmacometr Res Grp, Dept Pharmaceut Biosci, Uppsala, Sweden
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2016年 / 389卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
325
引用
收藏
页码：S76 / S76
页数：1
相关论文
共 50 条
  • [1] Piperacillin plasma concentrations are subtherapeutic in burn patients following a standard dosage regimen
    Olbrisch, K.
    Kisch, T.
    Thern, J.
    Kramme, E.
    Rupp, J.
    Graf, T.
    Wicha, S.
    Mailaender, P.
    Raasch, W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 : S13 - S13
  • [2] After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients
    Olbrisch, Katharina
    Kisch, Tobias
    Thern, Julia
    Kramme, Evelyn
    Rupp, Jan
    Graf, Tobias
    Wicha, Sebastian G.
    Mailaender, Peter
    Raasch, Walter
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (02) : 229 - 241
  • [3] After standard dosage of piperacillin plasma concentrations of drug are subtherapeutic in burn patients
    Katharina Olbrisch
    Tobias Kisch
    Julia Thern
    Evelyn Kramme
    Jan Rupp
    Tobias Graf
    Sebastian G. Wicha
    Peter Mailänder
    Walter Raasch
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 229 - 241
  • [4] Subtherapeutic piperacillin concentrations in neurocritical patients
    Damen, Caroline
    Dhaese, Sofie
    Verstraete, Alain G.
    Stove, Veronique
    De Waele, Jan J.
    JOURNAL OF CRITICAL CARE, 2019, 54 : 48 - 51
  • [5] Piperacillin/tazobactam treatment in children: evidence of subtherapeutic concentrations
    Ye, Panpan
    Shi, Jinyi
    Guo, Zixuan
    Yang, Xinmei
    Li, Qian
    Chen, Keguang
    Zhao, Furong
    Zhou, Haiyan
    Zhang, Yehui
    van den Anker, John
    Song, Linlin
    Zhao, Wei
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [6] Standard dosing of piperacillin and meropenem fail to achieve adequate plasma concentrations in ICU patients
    Petersson, J.
    Giske, C. G.
    Eliasson, E.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2016, 60 (10) : 1425 - 1436
  • [7] Measurement of piperacillin plasma concentrations in cancer patients with suspected infection
    Tobias Rachow
    Verena Schlüter
    Sibylle Bremer-Streck
    Udo Lindig
    Sebastian Scholl
    Peter Schlattmann
    Michael Kiehntopf
    Andreas Hochhaus
    Marie von Lilienfeld-Toal
    Infection, 2017, 45 : 629 - 636
  • [8] Measurement of piperacillin plasma concentrations in cancer patients with suspected infection
    Rachow, Tobias
    Schlueter, Verena
    Bremer-Streck, Sibylle
    Lindig, Udo
    Scholl, Sebastian
    Schlattmann, Peter
    Kiehntopf, Michael
    Hochhaus, Andreas
    von Lilienfeld-Toal, Marie
    INFECTION, 2017, 45 (05) : 629 - 636
  • [9] Standard dosing of amikacin and gentamicin in critically ill patients results in variable and subtherapeutic concentrations
    Roger, Claire
    Nucci, Bastian
    Molinari, Nicolas
    Bastide, Sophie
    Saissi, Gilbert
    Pradel, Gael
    Barbar, Saber
    Aubert, Clement
    Lloret, Sophie
    Elotmani, Loubna
    Polge, Anne
    Lefrant, Jean-Yves
    Roberts, Jason A.
    Muller, Laurent
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (01) : 21 - 27
  • [10] High prevalence of subtherapeutic plasma concentrations of efavirenz in children
    Ren, Yuan
    Nuttall, James J. C.
    Egbers, Claire
    Eley, Brian S.
    Meyers, Tammy M.
    Smith, Peter J.
    Maartens, Gary
    McIlleron, Helen M.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 45 (02) : 133 - 136
12345